|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue (Note 2, Note 18) | |||||
| Costs and expenses: | |||||
| Cost of sales (exclusive of depreciation and amortization as shown separately below) | |||||
| Selling and marketing | |||||
| Marketing | |||||
| Personnel (including stock-based compensation of $108, $120, and $96 - Note 13) | |||||
| Technology | |||||
| General and administrative | |||||
| Depreciation and amortization | |||||
| Impairment of goodwill | |||||
| Restructuring and other related reorganization costs (Note 7) | |||||
| Total costs and expenses | |||||
| Operating income (loss) | |||||
| Other income (expense): | |||||
| Interest expense | |||||
| Interest income | |||||
| Other income (expense), net (Note 16) | |||||
| Total other income (expense), net | |||||
| Income (loss) before income taxes | |||||
| (Provision) benefit for income taxes (Note 10) | |||||
| Net income (loss) | |||||
| Earnings (loss) per share attributable to common stockholders (Note 15): | |||||
| Basic | |||||
| Diluted | |||||
| Numerator used to compute earnings (loss) per share attributable to common stockholders (Note 15): | |||||
| Basic | |||||
| Diluted | |||||
| Weighted average common shares outstanding (Note 15): | |||||
| Basic | |||||
| Diluted |
Loading...
